Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
about
Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)(SL) miceThe Toll-->NFkappaB signaling pathway mediates the neuropathological effects of the human Alzheimer's Abeta42 polypeptide in DrosophilaRANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neuronsTranscriptomics of cortical gray matter thickness decline during normal agingProgranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?Mitochondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDsRANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.Anti-inflammatory agents and cognitive decline in a bi-racial population.Involvement of Fc receptors in disorders of the central nervous system.NSAIDs may protect against age-related brain atrophy.Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapyNeuroglobin and Alzheimer's dementia: genetic association and gene expression changes.Complementing the inflammasome.Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicityRNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegenerationExpression of Tau40 induces activation of cultured rat microglial cells.Inflammation induced by infection potentiates tau pathological features in transgenic mice.CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.Periodontal disease associates with higher brain amyloid load in normal elderly.WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line.Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray studyGranulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients.Rheumatoid Arthritis Was Negatively Associated with Alzheimer's Disease: A Population-Based Case-Control Study.Naringin and Rutin Alleviates Episodic Memory Deficits in Two Differentially Challenged Object Recognition TasksRAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective.Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo.Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial ParkinSystemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease.Toll-like receptors in neurodegeneration.Fibrosis of the Choroid Plexus Filtration Membrane.Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology.C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects.PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's diseaseBlueberry opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activation protein kinase
P2860
Q27339727-62CA02C1-27AA-4EE5-94E6-6EEBC8796C96Q28474328-79E7B13F-3346-4C1C-AE48-8104D5E7F7AAQ28567751-B5AD7C10-BEDB-4932-8EA3-C52F4CE7BC17Q30543926-E9457E4B-DAB6-4FF4-9F77-3986B30C140CQ30592224-14477476-82C3-4317-A4F8-999B575A4156Q30855123-8DF281D8-748F-4922-8227-4814A744691BQ33354062-CEA894DB-7745-4C9D-B843-A821B56F059AQ33578739-F58D70AC-8BF7-4F60-8C63-5F328B819645Q33650969-8F92ACC4-2344-48AB-A427-9FC49E91F2D9Q33886574-A4C3A94E-D00B-496D-B909-E067324C6CA2Q34151315-0BECE2B0-B5B2-43AD-9B6D-E82117647974Q34219814-AA0CEE95-4455-4318-9E69-C26F2A1A2B81Q34259694-92910A49-1D41-4453-A8D6-59EE8A651074Q34501875-5E381C2B-B861-42C7-8131-DA860CA244ECQ34540588-B4EA52BD-E55A-45A2-90ED-7C03FAA08097Q35018234-E48EDB64-2548-4CBB-A363-50188360516CQ35022620-13368C3F-4462-43E5-80EC-7C0A848CFB2AQ35071072-28FD5AAB-5EE4-4E49-AB77-24D31F9740E3Q35213298-D3143C38-FC88-4BD0-B9D2-35B63880B855Q35447921-A5FF8574-F61F-434A-AFF5-C85D98091AF5Q35601542-F2EB0B49-7ACB-40F1-9000-AC7D23A72EA9Q35742545-F15DF320-42D0-40BB-8C64-EEBB9ACCB878Q35748268-A1CED0A5-950E-4AEF-8866-4E93AC2B4C51Q36164195-8A235720-5D80-4AD0-9010-CE88AE714556Q36173185-E07A9BB6-A43F-4F1F-BF6B-EC5020B4CDBBQ36229543-2DC5CB5F-0045-4FC1-AFB6-89B6ADF08414Q36687431-4ADE6A23-6EA5-427F-9619-91F425E80F64Q36942363-C2890049-A71D-4D6D-A0FE-39C72B0CEAA7Q37069901-04C6F6B8-FC29-4D71-B0B5-BFD14FF5D7C7Q37095615-074B29EC-737C-4393-B30A-94B903BC5A83Q37100751-2F6DF3FE-C4E9-46DC-A2E8-9D64C8C39F77Q37105896-27396416-3B80-4700-9BA0-9A9F66295A92Q37109476-B55AEFAA-4D35-473B-BE8C-1CC12BB50B6DQ37137397-B2E423E2-FFE8-49F9-928C-BA7188A07979Q37186287-8383EB22-C54D-469B-8B6D-D3F91E980A0AQ37241391-4FE13C5A-6B65-4D2E-885C-32B9373B66D2Q37269655-3C8017BC-BB99-43D2-BD25-4E00609C9292Q37300144-CFEEC32C-CB58-4A95-977A-0FAF160780E5Q37310632-D8CB2D6B-D270-4F2A-8C8D-06A3A5082BC2Q37362513-B572A280-EDCF-4D59-8B1E-071425A66D9A
P2860
Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
@ast
Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
@en
type
label
Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
@ast
Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
@en
prefLabel
Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
@ast
Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
@en
P2093
P1476
Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.
@en
P2093
Edith G McGeer
Joseph Rogers
Patrick L McGeer
P304
P433
P577
2006-01-01T00:00:00Z